ArticleAsia Pacific journal of clinical nutrition2026
Iron status from diet and serum in relation to biological aging acceleration: A NHANES cross-sectional study.
Article in Asia Pacific journal of clinical nutrition, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
BACKGROUND AND
objectivesIron is essential but potentially toxic; both deficiency and overload may affect aging. Population-level evidence linking iron exposure to biological aging is limited, and aging-based optimal iron ranges are undefined. We examined associations of total, dietary, and supplemental iron intake and serum iron with three biological age (BA) measures and derived optimal ranges. METHODS AND STUDY
designWe analyzed 13,284 U.S. adults (≥20 years) from NHANES 2007-2010 and 2015-2018. BA deviations (PA, GoldBA, LightBA) were derived from clinical biomarkers. Weighted linear and restricted cubic spline (RCS) models assessed associations; optimal ranges were exposure intervals with significantly beneficial associations. Models adjusted for demographics, lifestyle, comorbidities, and diet quality. Subgroup analyses examined sex, age, menopause, and chronic disease.
resultsDietary iron was associated with younger BA (PA β = -0.07; GoldBA β = -0.09 per 2-fold increase), whereas supplemental iron accelerated aging above 18 mg/day (GoldBA β = 0.35 for >18 mg/day). Serum iron showed the strongest benefit (GoldBA β = -0.25 per 2-fold increase), with a U/J-shaped optimal range of 15.2-18.8 µmol/L. Optimal ranges were also identified for total iron (15.7 - 37.3 mg/day) and dietary iron (≥13.6 mg/day). The optimal serum iron range varied by subgroup (wider in postmenopausal women and those with chronic diseases; interaction p <0.05).
conclusionsThe iron-aging relationship is source-dependent: dietary iron is protective, supplemental iron >18 mg/day is detrimental, and serum iron 15.2-18.8 µmol/L is optimal. Optimal ranges should be stratified by population.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.